Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Posted on by ScienceFather

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

  1. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    • Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
    • Year: 2024
    • Journal: Acta Neuropathologica
    • Volume: 148(1), Pages 2
  2. Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
    • Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
    • Year: 2024
    • Journal: Journal of Immunological Methods
    • Volume: 534, Article 113747
  3. Prion Protein: The Molecule of Many Forms and Faces
    • Authors: Kovač, V., Šerbec, V.Č.
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
    • Volume: 23(3), Article 1232
    • Citations: 21
  4. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
    • Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
    • Year: 2021
    • Journal: Journal of Allergy and Clinical Immunology
    • Volume: 148(2), Pages 621–626.e7
    • Citations: 36
  5. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
    • Authors: Kovač, V., Čurin Šerbec, V.
    • Year: 2018
    • Journal: Biomarker Insights
    • Volume: 13
    • Citations: 6
  6. Targeting malignant brain tumors with antibodies
    • Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
    • Year: 2017
    • Journal: Frontiers in Immunology
    • Volume: 8(SEP), Article 1181
    • Citations: 57
  7. Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
    • Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
    • Year: 2017
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 484(1), Pages 45–50
    • Citations: 10
  8. New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    • Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
    • Year: 2017
    • Journal: Zdravniski Vestnik
    • Volume: 86(5-6), Pages 177–184
  9. Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
    • Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
    • Year: 2016
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 481(1-2), Pages 1–6
    • Citations: 10
  10. Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
    • Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
    • Year: 2016
    • Journal: Molecules
    • Volume: 21(10), Article 1300
    • Citations: 9

 

 

BERNAITIS LAZER | Medical Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. BERNAITIS LAZER | Medical Microbiology | Best Researcher Award

Associate Professor at Nandha Siddha Medical College, India.

Dr. Bernaitis L is an accomplished academic and researcher specializing in Medical Microbiology. With over a decade of teaching experience, he has dedicated his career to educating future healthcare professionals across various disciplines. His commitment to research is evidenced by his extensive publication record, which includes 51 journal articles, highlighting his contributions to microbiological studies, especially in antimicrobial resistance and clinical microbiology. Dr. Bernaitis has also served on editorial boards for multiple scientific journals, reflecting his recognition within the academic community. He is actively engaged in advancing the field of microbiology through both research and teaching, striving to instill a passion for scientific inquiry in his students.

Professional Profile

Education

Dr. Bernaitis holds a Ph.D. in Medical Microbiology from Annamalai University, where he focused on the culture isolation and drug susceptibility testing of Mycobacterium species. He earned his Master’s degree in Medical Microbiology from Kasturba Medical College, Manipal, and a Bachelor of Siddha Medicine and Surgery from A.T.S.V.S Siddha Medical College. His educational background provides a strong foundation in both theoretical and practical aspects of microbiology and medicine. This diverse academic experience has equipped him with the knowledge and skills necessary to conduct advanced research and contribute significantly to the field.

Professional Experience

Dr. Bernaitis has accumulated over 10 years of teaching experience in microbiology and pathology, currently serving as an Associate Professor and Head of the Microbiology Department at Nandha Siddha Medical College and Hospital. Previously, he held positions at R.V.S Dental College and R.V.S Siddha Medical College, where he taught various health science courses. His roles have allowed him to mentor numerous students in allied health sciences, ensuring they acquire essential knowledge and practical skills. This extensive experience in academia has not only solidified his expertise in microbiology but also contributed to the growth of future healthcare professionals.

Research Interests

Dr. Bernaitis’s research interests are primarily focused on Medical Microbiology, particularly the study of antimicrobial resistance, drug susceptibility testing, and the therapeutic potential of medicinal plants. His Ph.D. thesis investigated the isolation of Mycobacterium species and their susceptibility to various drugs, contributing valuable insights to the field. He has conducted extensive research on the antimicrobial properties of natural compounds against resistant bacterial strains. Additionally, his work addresses critical public health issues, such as fungal infections and biofilm formation, demonstrating his commitment to understanding and combating infectious diseases.

Research Skills

Dr. Bernaitis possesses a wide range of research skills essential for conducting high-quality scientific investigations. He is proficient in culture isolation techniques, drug susceptibility testing, and various microbiological assays. His experience with statistical analysis and data interpretation enhances the reliability of his research findings. Additionally, he is skilled in utilizing advanced microscopy techniques for studying microbial structures and behaviors. His ability to engage in collaborative research and contribute to interdisciplinary projects further highlights his versatility as a researcher. Dr. Bernaitis’s comprehensive skill set positions him as a valuable asset in the field of microbiology.

Awards and Honors

Throughout his career, Dr. Bernaitis has received several accolades and recognitions for his contributions to microbiology and education. His significant publication record in peer-reviewed journals underscores his commitment to advancing scientific knowledge. He has been appointed to editorial boards of various esteemed journals, reflecting his influence and respect in the academic community. These roles not only highlight his expertise but also his dedication to promoting quality research and scholarship. While specific awards may not be listed in his CV, his sustained contributions and impact in his field position him as a notable figure deserving of recognition.

Conclusion:

Dr. Bernaitis L is a strong candidate for the Best Researcher Award, demonstrating significant contributions to the field of Medical Microbiology through a robust academic background, extensive research publications, and a commitment to teaching. By addressing the identified areas for improvement, he can further enhance his impact and recognition in the scientific community. His dedication to advancing knowledge in medical microbiology aligns well with the criteria for this prestigious award.

Publications Top Notes

  • Isolation and molecular characterization of multi-drug resistant uropathogenic Escherichia coli from urine samples: Insights into urinary tract infection management
  • The application and assessment of bacterial isolates for textile dye decolorization
    • Authors: Bernaitis Lazer, Arun K S, Bibin K Mathew, Prejish Chandran, Jomol P J, Anakha Vijayan
    • Year: 2024
    • Journal: Indian Journal of Microbiology Research
    • DOI: 10.18231/j.ijmr.2024.035
  • A 40-Day Evidence-Based Review of Amla Juice and Its Impact on Liver Function Parameters
    • Authors: Menaka M, Valarmathi C, Bernaitis L, Kaviyarasan M, Abishek M, Sivasubramaniyan S, Muthazhagan A
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13692179
  • Nature’s Defense: A Review of Antioxidant-Rich Foods and Their Impact on Health
    • Authors: Bernaitis L, Sethumathi P P, Menaka M, Hari Kumaran Y, Hari Kishor R R, Prasanna R, Abinaya P
    • Year: 2024
    • Journal: GJR Publication
    • DOI: 10.5281/ZENODO.13692594
  • The Role of Traditional Herbs Versus Fermented Foods in Enhancing Antioxidant Defense Mechanisms
    • Authors: Menaka M, Bernaitis L, Arivumathi E, Rushmitha K M, Vishnupriya K S, Karunya C
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13690597
  • Traditional Siddha Oral Hygiene Techniques vs. Modern Practices: A Comparative Study of Efficacy and Benefits
    • Authors: Bernaitis L, Menaka M, Kunthavi B, Sneha M, Sonali P, Tamil Vasanth N, Ravi Shankar R
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13690796
  • Artificial Intelligence in Predicting Outbreaks of Healthcare-Associated Infections
    • Authors: Bernaitis L, Shanthi T M, Shyamala K R, Shwetha R B, Sharujah S, Sivasubramaniyan S
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13692168
  • Decoding the Gut-Brain Axis: Physiological Insights and Their Influence on Mental Health Disorders
    • Authors: Manjula V, Bernaitis L, Dhanush K, Jayasurya T, Moulishwaran N, Dhanush M
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13690559
  • Epidemiology of Emerging Viral Infections in India: A Systematic Review
    • Authors: Bernaitis L, Menaka M, Rajarajeswari T, Karkuzhali K, Anitha K, Pradeesha M
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13690516
  • Impact of Gut Microbiota on Bone Health: Implications for Osteoporosis Prevention and Management in Postmenopausal Women
    • Authors: Shanthi T M, Bernaitis L, Varshini K, Isha I, Hariprashanth P R, Subashree S R
    • Year: 2024
    • Journal: Zenodo
    • DOI: 10.5281/ZENODO.13690781

 

 

 

 

Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14

 

 

Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Posted on by ScienceFather

Ms. Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Post Doctoral Fellow of Suzhou institute of Nano tech and Nano bionics, China.

Wajiha Ahmed is a distinguished researcher from Pakistan with a diverse background in biomaterials and biology. She earned her PhD from Zhejiang University, China, where she focused on immune regulation and wound healing using innovative biomaterials like chiral polymers and ROS-responsive nanofibers. Her Master’s research involved plant-derived silver nanoparticles for chemical sensing, showcasing her early commitment to impactful research. Wajiha’s significant contributions are reflected in her nine peer-reviewed publications in reputable journals, including ACS Biomaterials Science & Engineering and Journal of Biomedical Materials Research Part A. Currently serving as Assistant General Manager at Global Clinical Cura Pvt. Limited, she combines academic expertise with industry experience. Her research addresses critical health issues, particularly in wound healing for diabetic and infectious wounds, emphasizing her dedication to advancing medical science. Wajiha’s international experience and impactful research make her a strong candidate for the Best Researcher Award.

Profile
Education

Wajiha Ahmed’s educational journey reflects a strong foundation in biotechnology and biomedical sciences, coupled with advanced research experience in biomaterials. She earned her PhD from Zhejiang University, China, where she specialized in biomaterials with a focus on immune regulation and wound healing. Her doctoral research involved innovative projects such as developing ROS-responsive polymer nanofibers and exploring the impact of enantiomeric polylysine on inflammatory responses, showcasing her expertise in cutting-edge biomedical applications. Prior to her PhD, Wajiha completed her Master’s degree in Biomedical Sciences and Engineering from the National University of Sciences and Technology (NUST), Islamabad, Pakistan. Her Master’s thesis centered on the chemical sensing of carcinogens using plant-derived fluorescent flavonoids, demonstrating her ability to integrate biological and chemical sciences. Wajiha’s academic journey began with a Bachelor’s degree in Biotechnology from the Islamia University of Bahawalpur, Pakistan, where she gained a solid grounding in the life sciences.

Professional Experience

Wajiha Ahmed has a diverse professional background, blending academic and industry experience. She currently serves as the Assistant General Manager at Global Clinical Cura Pvt. Limited, a role she has held since January 2021, where she manages key clinical operations, contributing to the company’s strategic goals. Prior to this, Wajiha held academic positions, including as a Visiting Lecturer at Shifa Tameer-e-Millat University in Islamabad, Pakistan, from February 2016 to 2017, where she was involved in teaching and curriculum development. She also served as a Lecturer at Fazaia Intercollege Jinnah Camp in Islamabad from February 2016 to August 2017, and as a Teacher at Springfield Public School and College in Rawalpindi from March 2014 to 2015. These roles allowed her to hone her teaching skills and foster a deep commitment to education. Her professional experience reflects a solid foundation in both educational and managerial capacities.

Research Interest

Wajiha Ahmed’s research interests are deeply rooted in the interdisciplinary fields of biomaterials and biomedical engineering, with a particular focus on developing innovative solutions for wound healing and immune regulation. Her work spans the synthesis and characterization of advanced materials such as chiral polymers, ROS-responsive polymer nanofibers, and plant-derived silver nanoparticles. Wajiha is particularly interested in exploring the interactions between biomaterials and biological systems, aiming to enhance therapeutic outcomes in conditions such as diabetic wounds and chronic inflammations. Her PhD research on multifunctional drug-loaded nanofibers for smart wound healing and the immune modulation of bone marrow-derived macrophages highlights her dedication to addressing critical health challenges through material science. Additionally, her background in chemical sensing of carcinogens using plant-based materials underscores her commitment to environmental and health safety, making her research both impactful and socially relevant.

Research Skills

Wajiha Ahmed is an accomplished researcher with a robust set of skills in biomaterials and biomedical sciences. Her expertise lies in the synthesis and characterization of advanced nanomaterials, including chiral polymers and ROS-responsive polymer nanofibers, which she has applied to critical areas such as immune regulation and wound healing. Wajiha is proficient in various laboratory techniques, including nanoparticle synthesis, polymer grafting, and in vitro cellular assays. Her ability to design and conduct complex experiments is evident in her contributions to high-impact research projects. Additionally, she is skilled in data analysis and interpretation, employing advanced analytical tools to derive meaningful insights from experimental results. Wajiha’s research is also characterized by strong interdisciplinary collaboration, allowing her to integrate biological, chemical, and material science principles effectively. Her publications in reputable journals further reflect her dedication to advancing knowledge in the field of biomaterials.

 Awards and Recognition

Wajiha Ahmed has earned recognition for her exceptional contributions to the field of biomaterials and biology. Her innovative research on immune regulation, wound healing, and chemical sensing has been published in reputable journals, highlighting her impact on advancing scientific knowledge. Wajiha’s work has been acknowledged through her role as a first and co-author in multiple peer-reviewed publications, reflecting her dedication and expertise. Her international research experience, particularly during her PhD at Zhejiang University, has further solidified her reputation as a promising researcher in her field. Additionally, Wajiha’s involvement in interdisciplinary projects and her ability to address critical health challenges, such as diabetic wound healing, underscore her commitment to research that has tangible societal benefits. While she is still in the early stages of her career, her accomplishments have already positioned her as a rising star in biomaterials research, earning her respect and recognition among her peers.

Conclusion

Wajiha Ahmed is a strong candidate for the Best Researcher Award, given her significant contributions to biomaterials research, her impressive publication record, and her international research experience. To further strengthen her candidacy, she could focus on expanding her industrial collaborations and increasing her public engagement efforts. Overall, her multidisciplinary expertise and commitment to addressing societal challenges through research make her a suitable and competitive nominee for the award.

Publications Top Notes

  • Bi-layered Polyurethane Nanofiber Patches with Asymmetrical Surface Prevent Postoperative Adhesion and Enhance Cardiac Repair
    • Authors: Li, S., Ahmed, W., Wang, S., Zhu, Y., Gao, C.
    • Year: 2024
    • DOI: 10.1016/j.compositesb.2024.111668
  • Taking Chiral Polymers Toward Immune Regulation
    • Authors: Ahmed, W., Karabaliev, M., Gao, C.
    • Year: 2022
    • Citations: 6
    • DOI: 10.1002/pol.20220163
  • Influence of Enantiomeric Polylysine Grafted on Gold Nanorods on the Uptake and Inflammatory Response of Bone Marrow-Derived Macrophages in Vitro
    • Authors: Ahmed, W., Zhang, H., Gao, C.
    • Year: 2022
    • DOI: 10.1002/jbm.a.37068
  • Reactive Oxygen Species-Responsive and Scavenging Polyurethane Nanoparticles for Treatment of Osteoarthritis In Vivo
    • Authors: Zhang, H., Xiong, H., Ahmed, W., Fan, C., Gao, C.
    • Year: 2021
    • Citations: 39
    • DOI: 10.1016/j.cej.2020.128147
  • Adaptive Antibacterial Biomaterial Surfaces and Their Applications
    • Authors: Ahmed, W., Zhai, Z., Gao, C.
    • Year: 2019
    • Citations: 134
    • DOI: 10.1016/j.mtbio.2019.100017
  • Design and Applications of Cell-Selective Surfaces and Interfaces
    • Authors: Zhang, H., Zheng, X., Ahmed, W., Chen, Y., Gao, C.
    • Year: 2018
    • Citations: 35
    • DOI: 10.1021/acs.biomac.8b00492